Trial record 7 of 23 for:    Tysabri | Open Studies

CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2012 by Elan Pharmaceuticals
Sponsor:
Collaborator:
Biogen Idec
Information provided by:
Elan Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00707512
First received: June 27, 2008
Last updated: March 15, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)